Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Medicine Lab, |
RCV001375954 | SCV001572942 | uncertain significance | Cardiac anomalies - developmental delay - facial dysmorphism syndrome | 2020-06-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005369867 | SCV006030550 | uncertain significance | Inborn genetic diseases | 2025-02-27 | criteria provided, single submitter | clinical testing | The c.3033C>G (p.D1011E) alteration is located in exon 17 (coding exon 17) of the MED13L gene. This alteration results from a C to G substitution at nucleotide position 3033, causing the aspartic acid (D) at amino acid position 1011 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |